Problem statement: Answer the multiple-choice question.
Question: Which compound has a -10.021% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] Cc1ccc(Oc2nc(-c3ccccc3)ncc2S(C)(=O)=O)cc1
[b] O=C(Nc1ccccn1)c1ccc(Cl)c(S(=O)(=O)N2CCc3ccccc32)c1
Answer: b. O=C(Nc1ccccn1)c1ccc(Cl)c(S(=O)(=O)N2CCc3ccccc32)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(Nc1ccccn1)c1ccc(Cl)c(S(=O)(=O)N2CCc3ccccc32)c1
O=C(Nc1ccccn1)c1ccc(Cl)c(S(=O)(=O)N2CCc3ccccc32)c1
4-chloro-3-(2,3-dihydroindol-1-ylsulfonyl)-N-pyridin-2-ylbenzamide